VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,861,201 | -55.8% | 135,755 | -48.3% | 0.04% | -46.1% |
| Q2 2023 | $4,210,798 | +80.9% | 262,355 | -12.5% | 0.08% | +117.1% |
| Q1 2023 | $2,328,000 | -70.9% | 300,000 | -27.5% | 0.04% | -64.3% |
| Q4 2022 | $8,010,900 | -28.2% | 414,000 | -20.9% | 0.10% | -26.9% |
| Q3 2022 | $11,154,000 | +178.5% | 523,400 | +77.8% | 0.13% | +185.1% |
| Q2 2022 | $4,005,000 | +184.2% | 294,300 | +390.5% | 0.05% | +213.3% |
| Q1 2022 | $1,409,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |